Skip to main content

Table 1 Baseline characteristics of ATA-negative and ATA-positive patients

From: The impact of thyroid autoantibodies on the cycle outcome and embryo quality in women undergoing intracytoplasmic sperm injection

Variable

ATA negative (n = 250)

ATA positive (n = 65)

p

Female age (years)

31.4 ± 4.5

31.1 ± 4.9

0.47

BMI (kg/m2)

26.0 ± 19.6

25.8 ± 5.7

0.27

Duration of infertility (years)

4.9 ± 3.6

5.0 ± 4.3

0.70

Basal FSH (mIU/mL)

7.0 ± 2.4

6.9 ± 3.2

0.43

Basal E2 (pg/mL)

41.1 ± 29.5

49.3 ± 22.9

0.67

AMH (ng/mL)

4.3 ± 3.0

3.8 ± 2.3

0.34

TSH (μIU/L)

1.9 ± 0.8

1.8 ± 0.9

0.44

Free T3 (ng/dL)

3.2 ± 0.4

3.2 ± 0.4

0.86

Free T4 (ng/dL)

1.3 ± 0.2

1.5 ± 0.4

0.001

  1. ATA anti-thyroid antibody, BMI body mass index, FSH follicle-stimulating hormone, E2 estradiol, AMH anti-mullerian hormone, TSH thyroid-stimulationg hormone
  2. Values are mean ± SD